{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:48:15Z","timestamp":1767768495667,"version":"3.48.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fondation Coeur Daniel Wagner","award":["YMCA project"],"award-info":[{"award-number":["YMCA project"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiac arrest (CA) is a major cause of mortality and morbidity. Accurate prediction of neurological outcome and survival remains challenging. In this context, our study aimed to explore novel molecular biomarkers that could provide additional insights into the pathophysiology of brain injury after CA and potentially distinguish patients with no brain injury (CPC 1) from those with any degree of neurological damage from moderate injury up to death (CPC 2\u20135), and complement existing prognostic tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Whole blood samples collected 48\u00a0h after return of spontaneous circulation were analyzed by RNA sequencing in a subgroup of 50 CA patients from the monocenter North Pole cohort, and by quantitative PCR in 233 patients from the same cohort as well as in 511 patients from the multicenter TTM trial. The association of gene expression changes with 6-month neurological outcome (assessed by the Cerebral Performance Category (CPC) score) and survival was studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In a discovery phase with a subset of 50 patients from the North Pole cohort (25 CPC 1 and 25 CPC 5), direct RNA sequencing identified the solute carrier family 2 member 1 (SLC2A1), a gene encoding a major glucose transporter at the blood\u2013brain barrier (GLUT1), as significantly upregulated in CPC 5 patients (dead with severe neurological impairment) compared to survivors without neurological sequelae (CPC 1). This upregulation was confirmed by quantitative PCR and extended to the entire North Pole cohort (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). SLC2A1 was an independent predictor of neurological sequelae or death in this cohort. In the TTM trial, SLC2A1 was also upregulated in patients with neurological sequelae or death (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and was an independent predictor of neurological sequelae or death, providing an incremental predictive value to a baseline clinical model (odds ratio\u2009=\u20092.06, 95% confidence interval 1.31\u20133.4,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20092.82E-03, and likelihood ratio test\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Blood level of SLC2A1 is a tentative blood biomarker that may aid in neurological outcome prediction after CA and also provide new insights into post-CA injury mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40635-025-00851-8","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:46:48Z","timestamp":1767768408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Direct RNA sequencing identified solute carrier family 2 member 1 to improve neurological outcome prediction after cardiac arrest"],"prefix":"10.1186","volume":"14","author":[{"given":"Victoria","family":"Stopa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miron","family":"Sopic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Lumley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Stammet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Schrag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ondrej","family":"Smid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hassager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Kjaergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Pellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janneke","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kuiper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Hovdenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Rylander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt P.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5321-8543","authenticated-orcid":false,"given":"Yvan","family":"Devaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"6","key":"851_CR1","first-page":"613","volume":"27","author":"DS Zimmerman","year":"2021","unstructured":"Zimmerman DS, Tan HL (2021) Epidemiology and risk factors of sudden cardiac arrest. Curr Opin Crit Care 27(6):613\u2013616","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"851_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.aan.2016.07.003","volume":"34","author":"ML Riess","year":"2016","unstructured":"Riess ML (2016) New developments in cardiac arrest management. Adv Anesth 34(1):29\u201346","journal-title":"Adv Anesth"},{"key":"851_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.resuscitation.2021.02.007","volume":"161","author":"JT Grasner","year":"2021","unstructured":"Grasner JT, Herlitz J, Tjelmeland IBM, Wnent J, Masterson S, Lilja G et al (2021) European Resuscitation Council Guidelines 2021: epidemiology of cardiac arrest in Europe. Resuscitation 161:61\u201379","journal-title":"Resuscitation"},{"issue":"12","key":"851_CR4","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00134-021-06548-2","volume":"47","author":"C Sandroni","year":"2021","unstructured":"Sandroni C, Cronberg T, Sekhon M (2021) Brain injury after cardiac arrest: pathophysiology, treatment, and prognosis. Intensive Care Med 47(12):1393\u20131414","journal-title":"Intensive Care Med"},{"issue":"1","key":"851_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-03913-5","volume":"26","author":"J Humaloja","year":"2022","unstructured":"Humaloja J, Ashton NJ, Skrifvars MB (2022) Brain injury biomarkers for predicting outcome after cardiac arrest. Crit Care 26(1):81","journal-title":"Crit Care"},{"key":"851_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.resuscitation.2021.02.012","volume":"161","author":"JP Nolan","year":"2021","unstructured":"Nolan JP, Sandroni C, B\u00f6ttiger BW, Cariou A, Cronberg T, Friberg H et al (2021) European resuscitation council and European society of intensive care medicine guidelines 2021: post-resuscitation care. Resuscitation 161:220\u2013269","journal-title":"Resuscitation"},{"issue":"1","key":"851_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1670-9","volume":"21","author":"MS Sekhon","year":"2017","unstructured":"Sekhon MS, Ainslie PN, Griesdale DE (2017) Clinical pathophysiology of hypoxic ischemic brain injury after cardiac arrest: a \u201ctwo-hit\u201d model. Crit Care 21(1):90","journal-title":"Crit Care"},{"key":"851_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2024.110187","volume":"198","author":"DJ Barton","year":"2024","unstructured":"Barton DJ, Elmer J (2024) Open for business: the blood\u2013brain barrier after cardiac arrest. Resuscitation 198:110187","journal-title":"Resuscitation"},{"key":"851_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052777","author":"M Bhomia","year":"2024","unstructured":"Bhomia M, Feng Y, Deleon P, Robertson CS, Kobeissy F, Wang KK et al (2024) Transcriptomic signatures of neuronally derived extracellular vesicles reveal the presence of olfactory receptors in clinical samples from traumatic brain injury patients. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25052777","journal-title":"Int J Mol Sci"},{"issue":"1","key":"851_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pcad.2012.06.003","volume":"55","author":"DM Pedrotty","year":"2012","unstructured":"Pedrotty DM, Morley MP, Cappola TP (2012) Transcriptomic biomarkers of cardiovascular disease. Prog Cardiovasc Dis 55(1):64\u201369","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"851_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-022-00470-7","volume":"10","author":"FM Stefanizzi","year":"2022","unstructured":"Stefanizzi FM, Zhang L, Salgado-Somoza A, Dankiewicz J, Stammet P, Hassager C et al (2022) Circular RNAs to predict clinical outcome after cardiac arrest. Intensive Care Med Exp 10(1):41","journal-title":"Intensive Care Med Exp"},{"key":"851_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.yebeh.2018.06.010","volume":"91","author":"H Koch","year":"2019","unstructured":"Koch H, Weber YG (2019) The glucose transporter type 1 (Glut1) syndromes. Epilepsy Behav 91:90\u201393","journal-title":"Epilepsy Behav"},{"issue":"9","key":"851_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jacc.2013.04.039","volume":"62","author":"P Stammet","year":"2013","unstructured":"Stammet P, Wagner DR, Gilson G, Devaux Y (2013) Modeling serum level of s100beta and bispectral index to predict outcome after cardiac arrest. J Am Coll Cardiol 62(9):851\u2013858","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"851_CR14","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1056\/NEJMoa1310519","volume":"369","author":"N Nielsen","year":"2013","unstructured":"Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C et al (2013) Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med 369(23):2197\u20132206","journal-title":"N Engl J Med"},{"issue":"9","key":"851_CR15","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell H (2020) Glucose transporters in brain in health and disease. Pflugers Arch 472(9):1299\u20131343","journal-title":"Pflugers Arch"},{"issue":"11","key":"851_CR16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/02699052.2025.2492751","volume":"39","author":"JT Li","year":"2025","unstructured":"Li JT, Ou D, Shi YM, Bao L, Li YL, Xiong TT et al (2025) Post-cerebral ischemia energy crisis: the role of glucose metabolism in the energetic crisis. Brain Inj 39(11):893\u2013903","journal-title":"Brain Inj"},{"issue":"3","key":"851_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jamacardio.2016.0480","volume":"1","author":"Y Devaux","year":"2016","unstructured":"Devaux Y, Dankiewicz J, Salgado-Somoza A, Stammet P, Collignon O, Gilje P et al (2016) Association of circulating MicroRNA-124-3p levels with outcomes after out-of-hospital cardiac arrest: a substudy of a randomized clinical trial. JAMA Cardiol 1(3):305\u2013313","journal-title":"JAMA Cardiol"},{"key":"851_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.resuscitation.2019.03.006","volume":"138","author":"R Tissier","year":"2019","unstructured":"Tissier R, Hocini H, Tchitchek N, Deye N, Legriel S, Pichon N et al (2019) Early blood transcriptomic signature predicts patients\u2019 outcome after out-of-hospital cardiac arrest. Resuscitation 138:222\u2013232","journal-title":"Resuscitation"},{"issue":"3","key":"851_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nmeth.4577","volume":"15","author":"DR Garalde","year":"2018","unstructured":"Garalde DR, Snell EA, Jachimowicz D, Sipos B, Lloyd JH, Bruce M et al (2018) Highly parallel direct RNA sequencing on an array of nanopores. Nat Methods 15(3):201\u2013206","journal-title":"Nat Methods"},{"issue":"4","key":"851_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.14740\/cr1351","volume":"13","author":"AM Chaulin","year":"2022","unstructured":"Chaulin AM (2022) The metabolic pathway of cardiac troponins release: mechanisms and diagnostic role. Cardiol Res 13(4):190\u2013205","journal-title":"Cardiol Res"},{"key":"851_CR21","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1182\/blood-2019-131058","volume":"134","author":"A Paikari","year":"2019","unstructured":"Paikari A, Goyal A, Cousin C, Petit V, Sheehan VA (2019) Association between GLUT1 and HbF levels in red blood cells from patients with sickle cell disease. Blood 134:2265","journal-title":"Blood"},{"issue":"8","key":"851_CR22","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1097\/CCM.0000000000002367","volume":"45","author":"O Borgquist","year":"2017","unstructured":"Borgquist O, Wise MP, Nielsen N, Al-Subaie N, Cranshaw J, Cronberg T et al (2017) Dysglycemia, glycemic variability, and outcome after cardiac arrest and temperature management at 33 degrees C and 36 degrees C. Crit Care Med 45(8):1337\u20131343","journal-title":"Crit Care Med"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00851-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-025-00851-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00851-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:46:50Z","timestamp":1767768410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40635-025-00851-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["851"],"URL":"https:\/\/doi.org\/10.1186\/s40635-025-00851-8","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The North Pole study was approved by the National Ethics Committee of Luxembourg (CNER N\u00b0200803\/05) and conducted in accordance with the Declaration of Helsinki and national regulations. Written informed consent was obtained from patients or their legal representatives when applicable. The TTM trial was conducted in compliance with national regulations and the Declaration of Helsinki. Ethical approval was obtained through national procedures in participating countries, and consent was either waived or obtained from patients or their families as required. The trial is registered at ClinicalTrials.gov (NCT01020916).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"3"}}